Navigation Links
Affymax Reports Phase 2 Clinical Dose Ranging Results of,Once-Per-Month Hematide for the Treatment of Anemia

risks relating to the continued safety and efficacy of Hematide in clinical development, the potential for once per month dosing, regulatory requirements and approvals, research and development efforts, industry and competitive environment, intellectual property rights and disputes and other matters that are described in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update any forward-looking statement in this press release.

Contact

Affymax, Inc.
Sylvia Wheeler, 650-812-8861
Executive Director, Corporate Communications


'"/>




Page: 1 2 3

Related medicine technology :

1. Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month Hematide for the Treatment of Anemia in Patients with Early- and End-Stage Chronic Kidney Disease
2. Affymax Announces Results From Phase 2 Clinical Trial of Hematide for the Treatment of Anemia in Dialysis Patients
3. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
4. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
5. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
6. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
7. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
8. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
9. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
10. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
11. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine

Post Your Comments:
(Date:11/27/2009).../ -- At the upcoming Radiological Society of North...yal Philips Electronics ( PHG, AEX: PHI) will demo...rmatics solutions designed to directly address the...ivering meaningful imaging innovations that reflec...y upgradability. This focus will enable Philips t...
(Date:11/25/2009)...PRNewswire/ -- Praxis Electronic Medical Records r...my of Family Physicians, (AAFP) Family Practice Ma...or improving medical quality, health maintenance, ...Stimulus legislation. Praxis also ranked #1 among ... in determining their salary. Finally, Praxis also...
(Date:11/25/2009)...ewswire-FirstCall/ -- Heska Corporation ( HSKA); (...tic and specialty products to the veterinary indus...tics Corporation for the supply of blood gas produ...market. ,, (Logo: http://www.newscom.com/c...Roche share the same passion for innovating in the...
Breaking Medicine Technology:Philips Helps Hospitals Strike Balance Between Innovation and Value 2Philips Helps Hospitals Strike Balance Between Innovation and Value 3Philips Helps Hospitals Strike Balance Between Innovation and Value 4Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Heroes of Chemistry for saving teeth clean water new high blood pressure drug 54594 1Heroes of Chemistry for saving teeth clean water new high blood pressure drug 54594 2Heroes of Chemistry for saving teeth clean water new high blood pressure drug 54594 3Heroes of Chemistry for saving teeth clean water new high blood pressure drug 54594 4Newly found DNA catalysts cleave DNA with water molecule 9589 1Newly found DNA catalysts cleave DNA with water molecule 9589 2Inherited risk factors increase odds of developing childhood acute lymphoblastic leukemia 9587 1Inherited risk factors increase odds of developing childhood acute lymphoblastic leukemia 9587 2Inherited risk factors increase odds of developing childhood acute lymphoblastic leukemia 9587 3
...W ROCHELLE, N.Y., May 13 Gene therapy to replace ...tive disease that is fatal by,age 8-12 years, was ...decline in treated children, according to a paper ...sue (Vol. 19 No. 5) of Human Gene Therapy, a,peer-...c. The paper is,available free online at http://w...
...pecific biomarkers for molecular tumor grade and e...n of individual patient outcome-, SAN DIEGO, May ... of an article describing the discovery, developme...iara MGI(SM) (Molecular Grade,Index), that improve...the,prediction of distant disease recurrence. The ...
Other Medicine Technology:Gene Therapy Slows Progression of Fatal Neurodegenerative Disease in Children 2AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients 2AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients 3AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients 4
(Date:11/27/2009)...ROCHESTER, N.Y., Nov. 27 /PRNewswire-USNewswire/ -...are provider and fortunately every year, new vacci...n. But do all vaccines boost immunity for the same...,booster shots, needed to keep immunity strong? ...rnal of the American Academy of Pediatrics, Michae...
(Date:11/27/2009)...cycling plus low-emission vehicles may reduce futu...RIDAY, Nov. 27 (HealthDay News) -- Encouraging cit...rs would offer much greater public health benefits.... researchers have found. , The study compared ...e urban land transport scenarios for London, Engla...
(Date:11/27/2009)... Multi-purpose bilingual coloring boo...r use by the business community to educate - infor...cts from Safety issues to Dinosuars to ABC,S and a...Saint Louis, MO (PRWEB) November 27, 2009 -- Today... or toys to keep them busy any hour of the day, bu...
(Date:11/26/2009)..., PRINCETON, N.J., Nov. 27 The dia...double over the next 25 years and annual medical s...llion, up from $113 billion today, according to a ... Care . The National Changing Diabetes ® Pr...ned the analysis by a team from the University of ...
(Date:11/26/2009)...igger thrill when on an emotional rollercoaster, s...Day News) -- Call it the fear factor meets the jub...pectators -- especially those who root for the win...,s a closely contested match and victory was in do... , Chew on that this Thanksgiving weekend as yo...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3
...GTON In a new collaboration, the Marian Koshland ... is licensing several components of its global war...ce Centre Singapore. The partnership marks an expa...d the world. , "We are very excited to join force...
... Ill., May 15 New research appearing in the,May i...sociation for,Psychological Science, suggests that...,s basic cognitive functioning and thus, their abi...alinsky of,the Kellogg School of Management at Nor...
... Energy Crisis One Sip At a Time, People across A... With,hectic, busy lifestyles, many Americans need...mmons invites New Yorkers to help solve their "ene...by to meet,the fitness guru and fuel-up on natural...
... only international volunteer service organization...and long-term needs, OAK BROOK, Ill., May 15 Tod...ounced that it is mobilizing US$1.5,million to aid...he powerful, massive,earthquake that struck Sichua...
... higher risk than Hispanics, but genetics determin...lthDay News) -- Genetic differences may explain wh...n Hispanic men, information which may help doctors... from south Texas and looked for mutations from th...
...e daily use of doctor-recommended proton pump inhi...isease (GERD) symptoms, nearly 40 percent of patie...ugh, which is a return of GERD symptoms, such as a...o a survey recently conducted by the American Gast...
Other Medicine News:Health News:Marian Koshland Science Museum forms partnership with Science Center Singapore 2Health News:Having Less Power Impairs the Mind and Ability to Get Ahead, Study Shows 2Health News:MultiVu Video Feed: Richard Simmons and Ocean Spray Team-Up to Solve 2Health News:Lions Mobilize $1.5 Million for China Earthquake Relief 2Health News:Lions Mobilize $1.5 Million for China Earthquake Relief 3Health News:Lions Mobilize $1.5 Million for China Earthquake Relief 4Health News:Genes Play Part in Prostate Cancer Among Races 2Health News:Nearly 40 percent of GERD patients taking PPIs experience recurring symptoms 2Health News:Nearly 40 percent of GERD patients taking PPIs experience recurring symptoms 3
...HEC is the first one-step 20 minutes rapid test fo... Enterohemorrhagic Escherichia coli in human speci...ernight enrichment of fecal specimens and detects ...00% specificity., The separate result for Toxin ...
Safilo TEAM Eyewear
Claiborne Eyewear Collection
Liz Claiborne Eyewear
Medicine Products: